Masimo (NASDAQ:MASI) Downgraded by Wolfe Research to “Hold”

Wolfe Research lowered shares of Masimo (NASDAQ:MASI) from a strong-buy rating to a hold rating in a research report released on Thursday morning,Zacks.com reports.

Several other equities analysts have also commented on the stock. Bank of America initiated coverage on shares of Masimo in a research report on Monday, November 17th. They set a “neutral” rating and a $162.00 price target for the company. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research report on Tuesday. Piper Sandler lowered shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target on the stock. in a research note on Tuesday. Zacks Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 24th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Masimo has an average rating of “Hold” and an average target price of $181.17.

Masimo Stock Performance

NASDAQ MASI traded up $0.04 during trading hours on Thursday, reaching $175.37. The company’s stock had a trading volume of 1,871,546 shares, compared to its average volume of 1,407,720. The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69. The business has a 50-day simple moving average of $138.40 and a 200 day simple moving average of $143.06. The stock has a market cap of $9.42 billion, a PE ratio of -16.64, a PEG ratio of 1.78 and a beta of 1.26. Masimo has a 52 week low of $125.94 and a 52 week high of $194.88.

Hedge Funds Weigh In On Masimo

Hedge funds have recently modified their holdings of the company. Global Retirement Partners LLC acquired a new stake in shares of Masimo in the fourth quarter valued at $27,000. Aster Capital Management DIFC Ltd bought a new stake in Masimo in the fourth quarter worth about $28,000. Los Angeles Capital Management LLC acquired a new stake in Masimo in the 4th quarter valued at about $31,000. MAI Capital Management boosted its position in shares of Masimo by 176.7% during the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 129 shares in the last quarter. Finally, Rothschild Investment LLC boosted its position in shares of Masimo by 12,950.0% during the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 259 shares in the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.